DCarnitine and DLCarnitine are not recommended because of their adverse physical side effects
High baseline triglycerides, for example, often correlate with greater improvement potential
2014, 80 (16), s-0034-1394493
doi: 10.3390/ijms232314631, Summary Keywords GLP-1/GIP dual agonist, metabolic regulation, obesity, obstructive sleep apnea, tirzepatide Citation Fang Q, Zhu Y, Rao M and Liu P (2026) GLP-1/GIP dual agonist tirzepatide in obstructive sleep apnea syndrome: mechanisms, evidence, and clinical perspectives
In May 2022, tirzepatide (marketed as Mounjaro) received FDA approval for improving blood sugar control in adults with type 2 diabetes, in combination with diet and exercise